From Our 2006 Archives
FDA OKs Generic Depression Drug
Generic Version of Lexapro Gets Green Light
Latest MedicineNet News
May 23, 2006 -- The FDA has approved a generic version of the antidepressant Lexapro (escitalopram oxalate).
The generic tablets will be available in three doses: 5 milligrams, 10 milligrams, and 20 milligrams. The drug is a selective serotonin reuptake inhibitor (SSRI), a family of drugs that also includes Prozac, Celexa, Zoloft, and Paxil .
Brand-name Lexapro -- made by Forest Laboratories, Inc. -- is the No. 2 antidepressant in filled prescriptions and the No. 3 antidepressant for total U.S. sales, as of February 2006, according to IMS Health Incorporated, a pharmaceutical market intelligence company.
The generic version of the drug will be made by Ivax Corp., a Miami-based subsidiary of Israel's Teva Pharmaceutical Industries.
A Teva news release states that “Teva is currently in patent litigation concerning this product” in a U.S. district court.
The FDA has not released detailed information on generic escitalopram oxalate's approval history and labeling.
SOURCES: FDA: “Drug Details: Escitalopram Oxalate (Generic Drug).” WebMD Medical Reference from “Making the Antidepressant Decision”: “Selective Serotonin Reuptake Inhibitors.” IMS Health Incorporated: “Commonly Requested Therapeutic Class and Product Information (updated February 2006.” News release, Teva. Associated Press.
© 2006 WebMD Inc. All rights reserved
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions